Trial Profile
Effects of olprinone on the incidence of postoperative atrial fibrillation in lung cancer patients with elevated BNP levels undergoing pulmonary resection.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 23 Oct 2015
Price :
$35
*
At a glance
- Drugs Olprinone (Primary)
- Indications Atrial fibrillation
- Focus Therapeutic Use
- 23 Oct 2015 New trial record